Hypertension

A new study suggests that amlodipine combined with hydrochlorothiazide or perindopril is more effective vs perindopril plus HCTZ for lowering blood pressure in black patients from sub-Saharan Africa.

A new cohort assessment shows white and African American men both have a lifetime hypertension risk of more than 80%.

Little is known on the underlying pulmonary arterial lesions in patients with this phenotype of COPD.

A new study of a blood pressure-monitoring mobile app reports patients with diabetes could reach better thresholds.

Recalls on Diovan (valsartan) began last July when the FDA detected trace amounts of a probable carcinogen in certain lots of the blood pressure drug.

A systematic review and meta-analysis of nearly 10,000 patients found systolic AOBP readings, under the right circumstances, should become the standard blood pressure test.

Inner-city African-American patients are 5 times more likely to have hypertensive emergency, according to a recent study.

The SPRINT MIND study did find that intensive treatment reduced the risk of mild cognitive impairment, a precursor to dementia.

The hypertension medication is again being recalled due to carcinogenic impurities.

The FDA has responded to the Janssen Pharmaceutical company's sNDA with a request for more data.

Once one of the country healthcare system's greatest successes, CVD and related mortality is rising again. What's its true cause?

The community-based program intent on improving black men's blood pressure care will revamp its practice headed into 2019.

This past year came with a multitude of new FDA approvals for antiretroviral therapies as well as research highlighting HIV and various comorbidities.

African-American patients with moderate or severe sleep apnea have twice, or 3.5 times, the risk of resistant hypertension, respectively.

Providers should be aware that periodontal disease may hinder the efficacy of blood pressure medication.

Since the PCSK9 inhibitors were approved for cholesterol management by the FDA in 2015, they have been frequently compared.

Prevalence of hypertension in HIV-positive persons is not attributed to antiretroviral drug treatment in largest adverse event surveillance study.

The septic shock therapy was approved by the FDA last December. How has it fared in its first year of real-world clinical use?

When compared with enalapril, in patients with acute decompensated heart failure, sacubitril–valsartan led to greater reduction in N-terminal pro–B-type natriuretic peptide (NT-proBNP), and reduced re-hospitalization for heart failure, and was well tolerated.

Ezetimibe 10 mg/day significantly reduced the incidence of atherosclerotic cardiovascular events in elderly patients with high LDL cholesterol compared to control.

In visits with overweight or obese children with high blood pressure, pediatricians either provide no communication about BP or unclear or dismissive statements, unless SBP is ≥120 mmHg.